СЕРДЕЧНО-СОСУДИСТАЯ ПАТОЛОГИЯ У ПАЦИЕНТОВ С COVID-19. ЧАСТЬ 1
Аннотация
Вспышка COVID-19, вызванная SARS-CoV-2, представляет собой величайшую медицинскую проблему современности. Наличие у пациента сопутствующей сердечно-сосудистой патологии предрасполагает к тяжелому течению и формированию неблагоприятных исходов COVID-19. В настоящее время известно, что инфекция SARS-CoV-2 приводит, с одной стороны, к обострению и декомпенсации уже имеющихся у пациента заболеваний сердечно-сосудистой системы, с другой стороны, – к возникновению острой сердечно-сосудистой патологии. Понимание воздействия COVID-19 на сердечно-сосудистую систему необходимо для оказания комплексной медицинской помощи тяжелобольным пациентам. В этом обзоре обобщены быстро меняющиеся данные о сердечно-сосудистой патологии, связанной с COVID-19.
Литература
Mitkovskaja NP, Karpov IA, Arutjunov GP, Grigorenko EA, Ruzanov DJu, Statkevich TV, Tarlovskaja EI. Koronavirusnaja infekcija COVID-19 (obzor mezhdunarodnyh nauchnyh dannyh) [Covid-19 coronavirus infection (overview of international research data)]. Neotlozhnaja kardiologija i kardioovaskuljarnye riski [Emergency cardiology and cardiovascular risks]. 2020;4(1):784-815. (Russian).
Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE [Internet]. Available from: https://coronavirus.jhu.edu/
Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra M. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819-824. http://doi.org/10.1001/jamacardio.2020.1096.
Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14(3):247-250. http://doi.org/10.1016/j.dsx.2020.03.013.
Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831-840. http://doi.org/10.1001/jamacardio.2020.1286.
Chen D, Li X, Song Q, Hu C, Su H, Dai J, Ye Y, Huang J, Zhang X. Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19). medRx- iv [Preprint]. 2020 [posted 2020 Febr 29]. Available from: https://www.medrxiv.org/content/10.1101/2020.02.27.20028530v1
Aksenova AJu. Faktor Fon Villebranda i povrezhdenie jendotelija: vozmozhnaja svjaz s COVID-19 [Von Willebrand factor and endothelial damage: a possible association with COVID-19]. Jekologicheskaja genetika [Ecological genetics]. 2020;18(2):135-138. (Russian).
Ivanov MB, Shustov EB, Litvincev BS, Rejnjuk VL, Fomichev AV, Sosjukin AE. Jendotelialnaja disfunkcija kak zveno patogeneza COVID-19 [Endothelial dysfunction as a link in covid-19 pathogenesis]. Medline.ru. Rossijskij biomedicinskij zhurnal. 2020;21(1):884-903. (Russian).
Zheng YY, Ma YT, Zheng JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-260. http://doi.org/10.1038/s41569-020-0360-5.
Li B, Yang J, Zhao F. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-538. http://doi.org/10.1007/s00392-020-01626-9.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease Control and prevention. JAMA. 2020;323(13):1239-1242. http://doi.org/10.1001/jama.2020.2648.
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA. 2020;323(16):1612-1614. http://doi.org/10.1001/jama.2020.4326.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng
Z. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. http://doi.org/10.1001/jama.2020.1585.
Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, Sepe PA, Resasco T, Camporotondo R, Bruno R, Baldanti F, Paolucci S, Pelenghi S, Iotti GA, Mojoli F, Arbustini E. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22(5):911-915. http://doi.org/10.1002/ejhf.1828.
Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, Ibrahim H, Friedman GH, Thompson C, Alviar CL, Chadow HL, Fishman GI, Reynolds HR, Keller N, Hochman JS. ST-Segment Elevation in Patients with Covid-19 – A Case Series. N Engl J Med. 2020;382(25):2478-2480. http://doi.org/10.1056/NEJMc2009020.
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-810. http://doi.org/10.1001/jamacardio.2020.0950.
Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a metaanalysis. ProgCardiovasc Dis. 2020;63(3):390-391. http://doi.org/10.1016/j.pcad.2020.03.001.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-818. http://doi.org/10.1001/jamacardio.2020.1017.
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang
Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observation study. Lancet Respir med. 2020;8(5):475-481. http://doi.org/10.1016/S2213-2600(20)30079-5.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S,
Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. http://doi.org/10.1016/S0140-6736(20)30566-3.
